France's LFB and Invivo add to Euro PP momentum
Laboratoire Français du Fractionnement et des Biotechnologies (LFB), the French biopharmaceutical company, announced on Tuesday that it had raised a €124m Euro private placement, as the Euro PP market gathers pace, according to bankers.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: